Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.
Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the relative bioavailability of clarithromycin 500
mg tablets (Ranbaxy Laboratories Limited) with that of BIAXIN® 500 mg tablets in healthy,
adult subjects under fasting conditions.